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Hazard ratio (95% conﬁdence interval),
EES vs SES P-value
MACE
Intervention strategy
2-stent technique 0.23 (0.07 – 0.74) 0.013
1-stent technique 1.30 (0.69 – 2.48) 0.42
LM bifurcation
Yes 0.45 (0.19 – 1.06) 0.067
No 1.04 (0.51 – 2.11) 0.918
TVR
Intervention strategy
2-stent technique 0.25 (0.08 – 0.80) 0.019
1-stent technique 1.15 (0.56 – 2.36) 0.703
LM bifurcation
Yes 0.33 (0.12 – 0.93) 0.036
No 1.03 (0.49 – 2.18) 0.934
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SConclusions: This prospective multicenter study conﬁrms the safety and performance
of the Axxess stent in bifurcation lesions.The low rate of events shows that the Axxess
dedicated stent is a good choice in treating bifurcation lesions.
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Background: Side branch (SB) occlusion is a serious complication during percuta-
neous coronary intervention (PCI) for bifurcation lesions. This study sought to
investigate the predictors and outcomes of SB occlusion after main vessel (MV)
stenting in coronary bifurcation lesions.
Methods: Consecutive patients undergoing PCI using drug-eluting stents for bifur-
cation lesions with SB 2.3 mm were enrolled. We selected patients treated with 1-
stent technique or MV stenting ﬁrst strategy. SB occlusion after MV stenting was
deﬁned as Thrombolysis in Myocardial Infarction ﬂow grade <3.
Results: SB occlusion occurred in 187 (8.4%) of 2227 bifurcation lesions. In multi-
variate analysis, independent predictors of SB occlusion were preprocedural percent
diameter stenosis of the SB 50% (odds ratio [OR] 2.34; 95% conﬁdence interval
[CI] 1.59-3.43; p<0.001) and the proximal MV 50% (OR 2.34; 95% CI 1.57-3.50;
p<0.001), SB lesion length (OR 1.03; 95% CI 1.003-1.06; p¼0.03), and acute
coronary syndrome (OR 1.53; 95% CI 1.06-2.19; p¼0.02). Of 187 occluded SBs, ﬂow
was restored spontaneously in 26 (13.9%) and by SB intervention in 103 (55.1%), but
not in 58 (31.0%). Jailed wire in the SB was associated with ﬂow recovery (74.8%
versus 57.8%, p¼0.02). Cardiac death or myocardial infarction occurred more
frequently in patients with SB occlusion than those without SB occlusion (adjusted
hazard ratio 2.34; 95% CI 1.15-4.77; p¼0.02).
Conclusions: Angiographic ﬁndings of the SB, proximal MV stenosis, and clinical
presentation are predictive of SB occlusion after MV stenting. Occlusion of sizable SB
is associated with adverse clinical outcomes.
TCT-392
Drug-coated balloon angioplasty for de-novo lesions in coronary bifurcations
Klaus Bonaventura1, Theresa Weichert1, Antonia Schulz2, Philip Steen1,
Annette Fengler1, Franz X. Kleber3
1Klinikum Ernst von Bergmann, Potsdam, Germany, 2Charite Universitaetsmedizin
Berlin, Berlin, Germany, 3Charite Universitätsmedizin Berlin, Berlin, Germany
Background: Treatment of coronary bifurcation lesions represents a challenging area
in interventional cardiology. When compared with nonbifurcation interventions,
bifurcation interventions have a lower rate of procedural success, higher procedural
costs, longer hospitalization, and a higher rate of clinical and angiographic restenosis.
A few small scale studies have reported promising immediate and mid-term results of
drug-coated balloon (DCB) compared to non-coated balloon or a mixed strategy of
DCB and bare metal stent in bifurcation lesions. We analyzed and compared the
safety, focused on the rates of late coronary thrombosis (LT), and the clinical follow-
up after DCB in bifurcation lesions without additional stenting - the so called “Drug-
eluting balloon (DEB) only strategy” in a clinical setting.
Methods: A retrospective review was done of 85 consecutive patients who underwent
percutaneous coronary intervention procedure in de-novo lesions with the paclitaxel
eluting balloon SeQuent Please at a high-volume Heart Center in Potsdam. DCB
was used for the treatment of bifurcation lesions in 38 patients in 38 interventions.
Dual antiplatelet therapy with aspirin and clopidogrel/prasugrel (DAPT) was recom-
mended after DCB angioplasty.
Results: Most represented Medina type was 0/0/1 (36.8%). The procedure was
successful in all patients. Additional stenting of the main branch was needed in 3
(7.9%) interventions. No MACE (cardiac death, myocardial infarction, target lesion
revascularization) occurred up to 30 days. Within 12 months after intervention none of
the patients (0%) patients needed a target lesion revascularization or had suffered from
coronary thrombosis. Duration of DAPT was 4.2  3.8 months.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: The DEB only strategy is a treatment option for patients with bifur-
cation lesions and offers favorable results regarding procedural success, a low risk of
coronary late thrombosis and a low rate of target lesion revascularization.
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Background: Although drug-eluting stents (DES) have markedly broadened indica-
tions for percutaneous coronary intervention (PCI), bifurcation lesion still remains
a challenge. We sought to evaluate the efﬁcacy and safety of everolimus-eluting stent
(EES) for the treatment of bifurcation coronary lesions in comparison to SES (siro-
limus-eluting stent).
Methods: We analyzed the large-scale Korean multi-center registry for bifurcated
coronary lesions, COBIS (Coronary Bifurcation Stenting) II registry. In this registry,
1,762 patients treated with EES (n ¼ 348) or SES (n ¼ 1,414) were enrolled.
Primary outcome was major adverse cardiac events (MACE), deﬁned as a composite
of cardiac death, nonfatal myocardial infarction, and target vessel revascularization
(TVR).
Results: In all bifurcation lesions, EES was comparable to SES regarding MACE,
cardiac death, and TVR rates in the overall population as well as in the 1:3 propensity
score-matched one within 2-year follow-up. However, in speciﬁc subpopulation such
as patients with left main (LM) bifurcation lesions or those treated with 2-stent
technique (table), EES was superior to SES in terms of TVR and MACE rate in the
matched population. The interaction between the type of drug eluting stents and the
intervention strategy was signiﬁcant for both MACE (P ¼ 0.011) and TVR (P ¼
0.030). There was no difference in clinical outcomes between the 2 DESs in non-LM
bifurcation lesions or in patients treated with 1-stent technique.Conclusions: In this large-scale Korean multi-center registry for bifurcated coronary
lesions, EES was superior to SES in patients undergoing complex bifurcation inter-
vention, such as LM bifurcation or two-stent technique PCI.
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Background: It has been unknown whether intentional effort to minimize residual
stenosis of side branch (SB) during percutaneous coronary intervention (PCI) for
coronary bifurcation lesion will improve long-term clinical outcomes or not.acts/POSTER/Bifurcation and Left Main Interventions B123
